Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Cassiopea S.p.A.
  6. News
  7. Summary
    SKIN   IT0005108359

CASSIOPEA S.P.A.

(SKIN)
  Report
Delayed Quote. Delayed Swiss Exchange - 01/17 11:30:34 am
39.3 CHF   -1.75%
2021Cosmo Closes Public Exchange Offer For Cassiopea After Amassing 97% Stake
MT
2021Missing Vessel Captain Found Dead At Harper Port
AQ
2021CASSIOPEA S P A : Press Release 1
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cassiopea S p A : Enters License, Supply Deals for Acne Treatment in North America

07/26/2021 | 02:58am EST


© MT Newswires 2021
All news about CASSIOPEA S.P.A.
2021Cosmo Closes Public Exchange Offer For Cassiopea After Amassing 97% Stake
MT
2021Missing Vessel Captain Found Dead At Harper Port
AQ
2021CASSIOPEA S P A : Press Release 1
PU
2021Cosmo Pharmaceuticals Secures Over 93% Stake in Cassiopea at Tender Closing
MT
2021CASSIOPEA S.P.A.(SWX : SKIN) dropped from Swiss Performance Index (Price Return)
CI
2021Cosmo Pharmaceuticals N.V. completed the acquisition of an additional 49.9% stake in Ca..
CI
2021Cosmo Pharmaceuticals to Start Additional Acceptance Period in Cassiopea Offer
MT
2021Cosmo Pharmaceuticals Wins Shareholders Nod For Cassiopea Stake Deal
MT
2021Cosmo Pharmaceuticals Raises Cassiopea Stake To Over 87%
MT
2021Cassiopea's Partner Launches Winlevi Acne Treatment In US
MT
More news
Financials
Sales 2020 0,59 M 0,68 M 0,68 M
Net income 2020 -12,3 M -14,0 M -14,0 M
Net cash 2020 2,58 M 2,94 M 2,94 M
P/E ratio 2020 -37,8x
Yield 2020 -
Capitalization 405 M 462 M 461 M
EV / Sales 2019 578x
EV / Sales 2020 805x
Nbr of Employees 11
Free-Float 41,2%
Chart CASSIOPEA S.P.A.
Duration : Period :
Cassiopea S.p.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CASSIOPEA S.P.A.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 40,00 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Diana Harbort Chief Executive Officer & Executive Director
Pierpaolo Guzzo Chairman & Chief Financial Officer
Luigi Moro Chief Scientific Officer
Alessandro Mazzetti Chief Medical Officer
Martina Cartwright Senior Director-Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
CASSIOPEA S.P.A.29.45%471
GILEAD SCIENCES, INC.-1.16%90 027
REGENERON PHARMACEUTICALS-2.58%64 327
VERTEX PHARMACEUTICALS6.58%59 510
WUXI APPTEC CO., LTD.-3.73%52 722
BIONTECH SE-23.97%47 338